On March 2nd 2017 WAKA is organising a satellite symposium “WAKA HPV NETWORK: HPV IN SUB-SAHARAN AFRICA” at the IPVC 2017 where ETiCCS and SAP will present their IT-based approach to cervical cancer screening in resource-limited regions. The meeting will take place in Meeting Room 1.43 at 3:00 – 4:30 pm.
On February 15th 2017 twelve midwives were trained in genital self sampling using the Evalyn Brush® at Gondar University Hospital as preparation of community wide HPV-screening project. Instructions for women to take part in the screening project are currently being prepared in Amharic.
- At least 80 per cent of women will contract HPV in their lifetime.
- 85 per cent who develop cancer die in developing countries.
- Taxing broadband and IT accessories such as smart phones is increasingly becoming counterproductive.
- There is mounting evidence that IT improves the lives of people and thereby would lead to the achievement of the SDGs.
Cervical cancer is the number one cause of death among Kenyan women. According to the World Health Organisation’s (WHO) 2016 Factsheet titled, Human Papillomavirus (HPV) and Cervical Cancer, most cervical cancers are caused by HPV.
At least 80 per cent of women will contract HPV in their lifetime. Of those who develop cancer, 85 per cent will die in developing countries. Unlike advanced countries that have well-established population-wide cervical cancer early detection programmes, developing countries lack the necessary infrastructure due to limited resources.
However, information technology (IT), has now brought new hope to significantly accelerate and simplify the screening approaches in less affluent and more remote parts of the world.
Collaboration between SAP’s Design and Co-Innovation Centre, Heidelberg University Hospital in Germany and the Moi Teaching and Referral Hospital, developed a digitised screening solution as part of the Emerging Technologies in Cervical Cancer Screening (ETiCCS) project in Eldoret.
It is a process that begins at a local clinic, followed by data being codified before it is uploaded into the cloud. The project started with a series of ‘Design Thinking’ workshops at the AppHaus Heidelberg (Germany) to optimize the cumbersome manual and paper-based process. A mobile solution connected to the cloud that also runs offline if no Internet is available, was the natural outcome of these workshops.
It connects the silos in the end-to-end screening process – from study recruitment, to data collection, to examination to remote data access to track the study’s progress from Kenya and Germany.
This was one of a kind solution, which African Media Agency reported early this month as having won an award in 2016 for improving lives according to user-centred design principles.
The process would be better if the internet was accessible and affordable in rural Kenya. It is no longer a secret that improving the lives of African people requires improved universal broadband infrastructure that is affordable, flexible policy and regulatory environment.
Taxing broadband and IT accessories such as smart phones is increasingly becoming counterproductive when new technologies like Internet of Things (IoT) and Big Data analytics are promising to comprehensively assist developing countries to leapfrog decades of dependence and backwardness.
It is possible that in the coming days the motivation from ETiCCS and collaboration with other cancer studies, we can build predictive models that would provide an even more robust solution to humanity.
There is need to break other national silos in research to bring together findings from other studies.
For example, a recent study by researchers from Kenya Medical Research Institute (Kemri), Britain’s Queen Mary University and Oxford University came up with striking conclusions linking the occurrence of cancer (including cervical cancer) in Nairobi to the tribal origin of afflicted people.
With such knowledge, it is therefore possible to develop some predictive model to target those whose infections are most likely to lead to cancer and provide targeted awareness programmes. More importantly, the studies could point to new unexplored areas that could lead to an eventual cure for cancer.
The Nairobi study could very well suggest that environment if not genetics plays in some way into the causes of cancer.
If new research points elsewhere then WHO’s suggestion of risk factors for HPV persistence and development of cervical cancer may put into question. These risk factors include early first sexual intercourse, multiple sexual partners, tobacco use and immunity suppression.
There is mounting evidence that IT improves the lives of people and thereby would lead to the achievement of the SDGs.
Developing countries like Kenya, therefore, must strive towards universal connectivity that enables access to ICTs. IT as demonstrated in the ETiCCS case has the power of doing that which we couldn’t do before. There is a greater need now than ever before to collaborate, leverage IT, build capacity and change the lives of people.
The writer is an associate professor at the University of Nairobi’s School of Business
Training in portable colposcopy at Gondar University
Portable colposcopes such as the Gynocular™, developed for remote settings, allow the visualization of the cervix with a high magnification in contrast to examination with the naked eye as done by standard VIA. The Gynocular™ also offers digital documentation of the findings and sharing of the image with remotely situated experts. The device is thus ideal for training, consultation and quality control. The method is suitable for screening used by nurses in peripheral clinics as confirmed several studies.
6 gynecologists and 6 nurse/midwives already experienced in VIA participated in this 5-day course that was facilitated by Dr(s) Alexander Luyten from Wolfsburg Women’s hospital and Katahauni Tagveri from Inselspital Bern. The training included both classroom and practical sessions and a post-training skills evaluation.
As a next step a field study is planned to appraise the value of nurse-led portable colposcopy for peripheral settings.
forbes.com (USA) | 19.01.2016
The Human Papilloma Virus (HPV) is the most common viral infection of the reproductive tract, with 80 percent of women infected with at least one type in their lifetime, according to Christine Donoto, Senior Writer at SAP. There are 100 types of the virus, with 13 of those being cancer causing. According to the WHO, HPV is related to nearly all cases of cervical cancer worldwide. Cervical cancer is the fourth most frequent cancer in women, with 85 percent of deaths occur in developing regions. However, early detection and treatment by using respective tests can prevent up to 80 percent of cases. The SAP Design & Co-Innovation Center team joined the Emerging Technologies in Cervical Cancer Screening (ETiCCS) project, giving ten tablet PCs to help out. ETiCCS plans to bring the solution closer to patients by eliminating the need for women to travel long hours to a health center, provide self-sampling kits in larger, more rural areas with an ultimate goal to screen eligible women across the entire country.
Click here for forbes.com (USA) >>
diginomica.com (UK) | 20.11.2015
In the developed world, regular screening, early detection and rapid treatment have led to positive long-term outcomes for women diagnosed with cervical cancer. In the developing world, the disease is still a killer. In Western Europe or Australia/New Zealand, for example, for every 100,000 women diagnosed with the disease, fewer than two will die from it, according to figures from the UN’s World Health Organization (WHO). In East Africa, it is closer to 30 (27.6). There, few women will ever be screened. For many of those diagnosed, treatment comes too late. Dr. von Knebel-Doeberitz’s Emerging Technologies in Cervical Cancer Screening (ETiCCS) project is currently a one-year study involving 800 women, delivered by the Moi Teaching and Referral Hospital in Eldoret, Kenya and funded by the German Federal Ministry of Education and Research. Much of the technology involved was provided for free by SAP and Intel. Roche, meanwhile, has provided the test kits. Dr. von Knebel-Doeberitz and his team worked with staff at the Design & Co-Innovation Center team at SAP’s AppHaus Heidelberg center, to design a mobile app that would work for the project, based on the company’s HANA Cloud Platform. This is designed to accelerate study recruitment and provision of cancer test results. SAP has produced a video showing the app at work. All patient data entered locally, along with test results, can be monitored remotely by staff at the Heidelberg University Hospital and, to ensure that the solution works in areas with patchy Internet connectivity, the local part of the tablet-based app can run in offline mode and be synchronized to the cloud via an Internet ‘dongle’ several times a day.
Click here for diginomica.com (UK) >>
As cervical cancer is the number one cause of death from cancer in Kenya, new methods for cancer screening are desperately required. Therefore the Heidelberg University Hospital initiated the Emerging Technologies in Cervical Cancer Screening (ETiCCS) project with the aim to implement an innovative healthcare screening approach in fragile infrastructures. The initial focus of ETiCCS is a one-year cervical cancer study with 800 women performed by the Moi Teaching and Referral Hospital in Eldoret, Kenya. This pilot study was funded by the German Federal Ministry of Education and Research. Subsequently it is planned to offer a self-sampling test in a larger, more rural area with the ultimate goal to screen eligible women across the entire country.
Given the high risk of data loss and duplication of the current paper-based screening process, the Heidelberg University Hospital reached out to SAP to digitize cervical cancer screening in fragile infrastructures like Kenya.